![Daina Vanags](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Storia della carriera di Daina Vanags
Precedenti posizioni note di Daina Vanags
Società | Posizione | Inizio | Fine |
---|---|---|---|
CBio Ltd.
![]() CBio Ltd. BiotechnologyHealth Technology CBio Ltd. focuses on developing new generation products for the treatment of autoimmune and inflammatory diseases. It develops and commercializes treatments for autoimmune diseases. The company focuses and develops technologies on commercializing its proprietary drug, XToll for autoimmune and inflammatory diseases. It develops technologies for the treatment of autoimmune and inflammatory diseases. The company also engages in the business of research, product development and clinical trials of the therapeutic drug XToll and development of variants to the company's Cpn10 technology. CBio was founded by Steve P. Jones on October 11, 2000 and is headquartered at Brisbane, Australia. | Direttore operativo | 19/10/2011 | 05/09/2012 |
Direttore Tecnico/Scientifico/R&S | 01/01/2004 | 05/09/2012 | |
Presidente | 01/01/2004 | 05/09/2012 | |
INVION LIMITED | Direttore operativo | 12/10/2011 | - |
Direttore Tecnico/Scientifico/R&S | 12/10/2011 | - |
Statistiche
Distribuzione geografica
Australia | 3 |
Posizioni
Chief Operating Officer | 2 |
Chief Tech/Sci/R&D Officer | 2 |
President | 1 |
Settori
Health Technology | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
INVION LIMITED | Health Technology |
Aziende private | 1 |
---|---|
CBio Ltd.
![]() CBio Ltd. BiotechnologyHealth Technology CBio Ltd. focuses on developing new generation products for the treatment of autoimmune and inflammatory diseases. It develops and commercializes treatments for autoimmune diseases. The company focuses and develops technologies on commercializing its proprietary drug, XToll for autoimmune and inflammatory diseases. It develops technologies for the treatment of autoimmune and inflammatory diseases. The company also engages in the business of research, product development and clinical trials of the therapeutic drug XToll and development of variants to the company's Cpn10 technology. CBio was founded by Steve P. Jones on October 11, 2000 and is headquartered at Brisbane, Australia. | Health Technology |
- Borsa valori
- Insiders
- Daina Vanags
- Esperienza